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Saudi Journal of Ophthalmology (2012) 26, 191–197Ophthalmic Pathology UpdateNon-viral microbial keratitis in childrenAbdullah G. Al-Otaibi, MD ⇑AbstractMicrobial (non-viral) keratitis is a serious vision-threatening condition. The management of microbial keratitis in children is partic-
ularly complicated by the children’s inability to cooperate during examinations and the lack of information prior to presentation.
Predisposing factors vary according to geographical location and age. Corneal trauma is the leading cause for microbial keratitis in
children, followed by systemic and ocular disease. Etiologic agents are most frequently Gram-positive and Gram-negative bacteria
commonly found in contact lens-related microbial keratitis. Mycotic keratitis is a major risk factor in tropical weather conditions,
particularly when associated with agricultural trauma. Early diagnosis, intensive drug treatment, and timely planned surgical inter-
vention may effectively improve the outcome of pediatric microbial keratitis.
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Corneal infection is a major cause of ocular morbidity and
blindness worldwide, both in developed and developing
countries.1 In developing countries, it is estimated that 1.5–
8 million of corneal ulcers occur each year.2,3,5 Srinivasan
et al.3 reported that ulceration of the cornea in South India
‘‘is a blinding disease of epidemic proportions.’’ Children
presenting with microbial keratitis are at risk of developing
irreversible ocular deficits, such as those resulting from
amblyopia.2,15 Therefore, the diagnosis and treatment of
microbial keratitis in children is of utmost importance. How-
ever, studies pertaining to microbial keratitis in children are
scarce. Nonetheless, it is known that the microbial etiology
and predisposing factors vary with geographic location and
age.4–8 In addition to the lack of knowledge, management
of microbial keratitis in children is hampered by the children’s
inability to provide complete medical history and to cooper-
ate during examination and treatment. Delay in management
may cause severe visual impairment.Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University
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tors, laboratory and clinical findings, treatment, and outcome
of microbial keratitis in children.Incidence of microbial keratitis
Despite the improvements in treatment options, infectious
microbial keratitis remains a significant cause of blindness
worldwide.4 The incidence of microbial keratitis is higher in
developing countries than in developed countries.5–7 Maurin
et al.58 found that the incidence of corneal related blindness
in children in tropical countries is 20 times higher than that in
children from developed countries. In a study supervised by
the World Health Organization (WHO) South-East Asia Re-
gional Office in New Delhi, it has been estimated that 6 mil-
lion cases of corneal ulcer occur every year in South-East
Asia.5 The incidence of microbial keratitis ranges from 113
per 100,000 in India5 to as high as 799 per 100,000 in Nepal.6
On the other hand, the incidence of microbial keratitis in the
United States was estimated to be 2–11 per 100,000.7j Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
6 October 2011; available online 13 October 2011.
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children. In agreement, in an epidemiological study of micro-
bial keratitis in Southern California, only 11% of the cases in-
volved children.8Predisposing factors
Trauma
The most common predisposing factor for microbial kera-
titis in children is trauma.8–14,42 Corneal trauma disrupts the
protective mechanism of the corneal epithelium, thereby
facilitating bacterial adhesion and accelerating subsequent
microbial penetration and replication.15,16 Different studies
showed a decrease of corneal ulcers following traumas in
adults59,60 which is a far more common predisposing factor
in rural areas where it accounts for up to 77.5% of cases.61
Children are less cautious than adults, and they do not under-
stand the inherent dangers associated with hazardous ob-
jects during their activities of daily life.52 Objects of trauma
include plant, metal, or plastic pieces, firecrackers, and pen-
cils. The history of trauma in childhood microbial keratitis was
reported in 26% to 58.8%.8,9,13
Contact lens
Contact lens wear is a common predisposing factor in
many developed countries.9,10 In fact, it has been considered
the leading cause of microbial keratitis in Taiwan.15 This can
be explained by the relatively high prevalence of refractive
errors and the popularity of contact lens use in these areas.
In particular, overnight orthokeratology (OK) was reported
to be associated with infectious keratitis in myopic teenagers.
Watt and Swarbrick56 have provided an analysis of the first 50
cases of microbial keratitis in overnight OK. Their findings
showed that 60% of the affected OK patients were 15 years
old or younger. Of interest, 30% of these OK-related cases
were caused by Acanthamoeba, as opposed to only 5% of
infections reported in regular contact lens wearers. However,
contact lens-related microbial keratitis cases are usually asso-
ciated with Pseudomonas micro-organisms. At all ages, Pseu-
domonas-mediated keratitis accounts for the largest mean
diameter of corneal ulcers, highest number of outpatient vis-
its, and poorest visual acuity outcome.55 Hence, potential vi-
sual complications should be considered when prescribing
overnight lenses.15
Systemic and ocular diseases
Systemic infections and malignancies are the main causes
in patients with severe systemic illness, especially in children
below the age of 4.8–10 Systemic diseases and malnutrition
reduce the wound healing process that may be an important
reason for an increased risk for childhood microbial Kerati-
tis.62 A wide range of systemic diseases, including hypoxic
encephalopathy, pulmonary stenosis, malnutrition, multiple
congenital abnormalities, and severe prematurity, was found
to be associated with microbial keratitis in children.8–11,13
Health-impaired infants should receive additional medical
attention to prevent microbial keratitis, to which they are
more susceptible.15 The relationship between the health sta-
tus and microbial keratitis in children was supported by twostudies analyzing the risk factors for microbial keratitis in In-
dian children, which highlighted the association of protein-
energy malnutrition, immunization profile, and low socioeco-
nomic background with the development of microbial
keratitis.12,16
Ocular conditions such as exposure keratopathy (Fig. 2),
trichiasis, and dry eye are major contributors to microbial ker-
atitis.2–4 Table 1 summarizes the risk factors reported in dif-
ferent studies.
Clinical features of microbial keratitis
Microbial keratitis presents a wide range of clinical
signs and symptoms. They include moderate to severe
pain of rapid onset, severe redness of the conjunctiva,
hazy vision, photophobia, discharge, and swollen lids.
Signs usually include corneal infiltrate (either central or
paracentral), epithelial defects over the infiltrate, inflam-
matory cells in the anterior chamber with or without
hypopyon, folds in Descemet’s membrane, and sometimes
endothelial inflammatory plaques. The wide spectrum of
clinical manifestations can result in the incorrect selection
of antimicrobial agents and a prolonged period of
resolution.28,46
Pathogenesis of microbial keratitis
To establish a corneal infection, micro-organisms have
to overcome the natural barriers present at the ocular sur-
face. The defense mechanisms include an intact epithelial
layer at the corneal surface and a tear film with antibacte-
rial properties. Physical trauma usually precedes invasion of
micro-organisms. Many bacteria display several adhesins on
fimbriated and nonfimbriated structures that may aid in
their adherence to the host corneal cells. After the success-
ful invasion of the corneal surface, bacteria can proliferate
and penetrate into the corneal stroma.47 The host re-
sponse is crucial for protecting the cornea, but, at the
same time, it can produce some of the pathology that is
associated with infectious keratitis. Polymorphonuclear neu-
trophils (PMNs) are found at the inflammatory site soon
after the infection. Their migration is associated with cor-
neal damage and ultimately scarring or perforation in se-
vere cases.48 Degranulation of PMNs releases host
enzymes and toxins that kill the invading bacteria and de-
grade the corneal stroma. Influx of PMNs is mediated, on
the one hand, by chemokines and cytokines that are pro-
duced by the host soon after the infection49 and, on the
other, by chemotactic bacterial peptides and endotoxins.50
The host inflammatory response is regulated by a different
network of chemokines and cytokines that are released
soon after infection to prevent further stromal damage
and to stimulate wound healing.51
Microbiology analysis
Normal flora of the conjunctiva
The normal ocular flora of newborns is acquired mainly
from the birth canal during normal delivery. It includes Lacto-
bacillus, Bifidobacterium, Corynebacterium, Peptostrepto-
coccus, coagulase-negative Staphylococcus, and
Table 1. Comparative analysis of reported case series of childhood microbial keratitis.
Source Location Risk factors (%) Rate of
Surgery (%)
Ormerod et al. 8 Southern California Trauma; ocular disease 28
Cruz et al. 9 Florida Trauma (44); prior corneal surgery (24); systemic disease (14);
contact lens wear (12)
14
Clinch et al. 10 New Orleans, LA and
Philadelphia, PA
Trauma (34); systemic disease (27); contact lens wear (24) 21
Kunimoto et al. 11 India Trauma (21); ocular disease (18); systemic disease (16);
contact lens wear (0)
16
Vajpayee et al. 12 India Trauma (38); systemic disease (24); ocular disease (12);
contact lens wear (0)
6
Singh et al. 14 India Trauma (69); unknown (29.8); contact lens wear (1) 2
Hsiao et al. 15 Taiwan Contact lens wear (40.7); Trauma (21); Ocular disease (14.8);
Systemic disease (11.1)
14.8
Song et al. 13 China Trauma (58.8); ocular disease (10);
previous corneal refractive surgery (5)
74
Non-viral microbial keratitis in children 193propionibacterium species.37 Streptococci mainly dominate
the normal conjunctival flora of older children, and coryne-
bacteria are more abundant toward adulthood.Microbiology spectrum
Bacteria
Non-viral microbial keratitis in children is caused mainly by
bacteria and, to a lesser extent, by fungi or parasites. Amoe-
bae such as Acanthamoeba sp. are more related to contact
lens-associated keratitis but are rarely reported in childhood
microbial keratitis.17,18
The rate of culture-positive specimens varies between re-
ports and is in the range of 48–87%. This wide range can
be explained by different laboratory facilities and previous
use of topical antibiotics prior to scraping.
Of the reported culture-positive groups, Staphylococcus
species were among the most common isolated organisms.
Staphylococcus aureus and Streptococcus pneumoniae are
the predominant Gram-positive bacteria and Pseudomonas
aeuroginosa is the main Gram-negative bacterium associated
with microbial keratitis in children.10–14
Coagulase-negative staphylococci, including S. epidermi-
dis, are the most common bacteria comprising the normal
conjunctival flora.19,20 These bacteria have been reported
to be associated with high incidence of microbial keratitis in
children.10–14
Like in adults, the microbial keratitis spectrum in children
varies according to the geographical location. Studies from
South California, Florida, and Taiwan reported a high rate
of isolates of P. aeuroginosa.8,11,15 Other studies conducted
in New Orleans, LA, Philadelphia, PA, and India have re-
ported a markedly lower prevalence of P. aeruginosa.10,12
In the United States and Taiwan, P. aeruginosa isolates were
associated with high number of contact lens-related corneal
ulcers. Poor contact lens hygiene in contact lens-related
keratitis was noted in two studies.10,15 Table 2 highlights
the incidence of different micro-organisms isolated in studies
on childhood microbial keratitis.Fungi
Fungal microbial keratitis in children has been reported in
several studies.9,10,12–14 A significant incidence of filamentous
fungi in childhood microbial keratitis in Southern cities of theUnited States, China, and India has been reported. This can
be attributed to the relation between fungal infection and
tropical climate. Keratomycosis tends to increase in humid
environment. Regardless of the geographical location, the
major predisposing factor for fungal keratitis is trauma in
the agricultural environment.13,14 The agricultural environ-
ment is rich in bacteria and fungi. Upon trauma caused by
plants or vegetable materials, micro-organisms penetrate
the cornea leading to keratitis.37
Several studies from different parts of the world show var-
iable incidence of fungal keratitis. Cruz et al.9 reported an
incidence rate of 18% of fungal microbial keratitis in children
in the United States. Song et al.13 reported that 48.7% of the
cases of childhood microbial keratitis in China is caused by
fungal micro-organisms. A large (213 children) retrospective
analysis of mycotic keratitis in India showed that Aspergillus,
followed by Fusarium species, were the major causative fungi
in childhood keratomycosis.21Diagnosis of microbial keratitis in children
Clinical examination
A complete medical history and thorough eye examination
focusing on characteristic clinical features are essential for an
etiological diagnosis.22,23 Despite the fact that it is not always
easy to obtain a detailed history and to perform a thorough
clinical exam on younger children, these measures should
not be compromised. Full eye examination and scraping of
the infected cornea are required under sedation or general
anesthesia when dealing with children who are suspected
to have microbial keratitis (Fig. 1). However, Thomas
et al.26 in a study investigating a possible correlation be-
tween clinical examination and the specific infecting agent
in microbial keratitis, concluded that the clinical features of
microbial keratitis may vary significantly and that no clinical
feature can be considered absolutely pathognomonic of a
particular type of infectious agent. Similar results were ob-
served in another study.25 Both studies concluded that clini-
cal examination alone cannot be taken as a basis for
deciding the therapeutic regimen that should be followed
for a specific microbial organism.24,25
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194 A.G. Al-OtaibiMicrobiology workup
Corneal scrapings in children require sedation or general
anesthesia, especially if they are less than 2 years of age.12
Corneal scraping smears are inoculated in blood, chocolate,
Sabouraud agar, Lowenstein–Jensen agar, and thioglycolate
broth. Cultures for Acanthamoeba are performed if indicated
by clinical appearance or history. In general, corneal scrap-
ings and microbiological examination yield positive cultures
in only 52–65% of cases.38–41 Microscopic slides are used
for stained smears with Gram, Giemsa, and acid-fast
staining/acridine orange/calcofluor white (if fungi or Acantha-
moeba are suspected).41Treatment
Antibacterial
Current therapeutic strategies to treating microbial kerati-
tis aim at eradicating the microbial agent and moderating the
host immune response with corticosteroids to reduce the
scarring while minimizing potential visual impairments. Topi-
cal application of the antimicrobial agents will lead to high
concentration of the drug at the infection site. Treatment of
microbial keratitis needs aggressive and frequent administra-
tion of the antimicrobial agents, which can be difficult when
treating children. At present, the standard treatment consists
of either fortified antibiotics – in the form of concentrated
aminoglycoside and cefazolin (e.g., tobramycin 1.3% and
cefazolin 5%) – or monotherapy with second-generation fluo-
roquinolone eye drops.26–29 In a 2003 review published in the
British Journal of Ophthalmology, about 75% of the corneal
ulcers were treated with fluoroquinolone monotherapy.57
The fourth-generation ophthalmic fluoroquinolones include
moxifloxacin and gatifloxacin are being used for the treat-
ment of bacterial conjunctivitis. Both antibiotics have better
in vitro activity against Gram-positive bacteria than ciproflox-
acin or ofloxacin. Moxifloxacin penetrates better into ocular
tissues than gatifloxacin against gram-negative bacteria is
similar to that of older fluoroquinolones.63,64
These findings suggest that, moxifloxacin or gatifloxacin
may ba a preferred alternative to ciprofloxacin as the first-line
monotherapy in bacterial keratitis. A more recent study33 did
not show any difference in the efficacy of monotherapy with
fourth-generation fluoroquinolones in the treatment of bac-
terial corneal ulcers when compared with combination ther-
apy of fortified antibiotics, which could reduce the
frequency of application of antimicrobial drugs in uncooper-
ative children.
In crying uncooperative children, regular topical adminis-
tration of the topical antibiotics is not feasible, which has
led some investigators to advocate repeated subconjuctival
injection under sedation and papoose restraint.8,31
Antifungal
Unlike antibiotics for bacteria, the spectrum of antifungal
medications is limited and more often associated with poor
corneal penetration and less antifungal activity against infect-
ing fungi, which make mycotic keratitis more prone to cor-
neal perforation and ocular complications, such as
endophthalmitis, in comparison to bacterial keratitis.30 None-
Non-viral microbial keratitis in children 195theless, topical natamycin (5%), fluconazole (0.5%), and
amphotericin B (0.25%) are known to be effective antifungal
drugs in treating childhood microbial keratitis.10,11,13Corticosteroids
The action of corticosteroids is known to slow down the
host inflammatory response and may hinder the eradication
of invading micro-organisms.53 The role of corticosteroid re-
mains controversial; however, when they are used, close fol-
low-up and strict guidelines are mandatory to ensure the best
outcome for these patients. In general, corticosteroids are
recommended for less severe cases of corneal ulceration that
are small in size and peripheral in location.38 They should not
be used until specific antimicrobial therapy has controlled
microbial proliferation, and clear clinical improvement is
evident.54Figure 2. Bilateral cryptophalmous with exposure keratopathy and
microbial keratitis in left eye.Outcome
Most ulcers, including those occurring in children below
the age of 3 years, are successfully treated with topical ther-
apy alone.9–11
The rate of surgical intervention (in the form of therapeutic
penetrating keratoplasty and conjunctival flaps, therapeutic
lamellar keratoplasty, and debridement, alone or in combina-
tion with amniotic membrane transplantation) is less than
20% in treated children with microbial keratitis in most of
the reports8–15 (Table 1).
One study from China13 reported high incidence of surgi-
cal intervention (74%). This figure is probably attributed to
the fact that majority of the patients lived in rural areas in Chi-
na and were exposed to agricultural activities, leading to a
high fungal infection rate (48.7%).
Severe protein-energy malnutrition and bilateral keratitis
cases have been associated with a higher rate of surgical
intervention. In general, patients without protein-energy mal-Figure 1. Corneal scar after microbial keratitis.nutrition were 36% less likely to have a poor outcome.16 On
the other hand, the visual prognosis for fungal keratitis in chil-
dren has been associated with poor outcome.32–35
Parmar et al. compared microbial keratitis in three differ-
ent groups: a pediatric group, an elderly group, and a control
group between 17 and 64 years of age. They found that
microbial keratitis in children was more likely to be associated
with bacterial infection, non severe ulcers, and more likely to
resolve with medical therapy alone when compared with
microbial keratitis in adults.36 A study published by Hsiao
et al.15 concluded that poor vision outcome was associated
with polymicrobial infection, fungal infection, systemic dis-
ease, and ocular disease.Summary
Pediatric microbial keratitis is an uncommon but poten-
tially serious condition. The causative micro-organisms of
(non-viral) microbial keratitis in children are predominantly
bacteria and to a lesser extent, fungi. Of the bacteria patho-
gens, Staphylococcus sp., S. pneumonia, and P. aeruginosa
are the most common. The risk factors for microbial keratitis
in children include trauma, severe systemic and ocular dis-
ease, and contact lens wear. Treatment for pediatric micro-
bial keratitis usually starts with application of fortified
topical antimicrobial drugs, followed by anti-inflammatory
agents. Children suffering from microbial keratitis are at risk
of amblyopia.15 Thus, early diagnosis and treatment is neces-
sary to minimize any vision-threatening complications.References
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